Verdict94/ 100
Grade A · #1CoreAge Rx
The most honest middle of the market: nationwide access, both molecules at one flat, no-surprise price.
Visit CoreAge RxHead-to-head verdict
CoreAge Rx vs Lttl
Two GLP-1 providers, ruled side by side on The Verdict Score — our published six-factor rubric. Same yardstick, and no score is adjusted for payment.
vs
Verdict61/ 100
Grade C · #303Lttl
A deep compounded menu — injectable, oral tablet and microdose — with a full public price matrix, but no named pharmacy and no published state list.
Visit LttlThe verdict
Winner: CoreAge Rx
CoreAge Rx takes it with a higher Verdict Score — 94/100 to 61/100 (grade A vs C). Anyone who wants transparent flat pricing and nationwide access without a teaser-rate bait-and-switch. Lttl still earns its place — shoppers comparing commitment lengths who want the true month-to-month rate visible, or who want an oral or low-dose option instead of a standard injection.
Factor by factor
Both scored on the same six factors — see the methodology. The brass bar marks the stronger side on each.
92Real-world results62
92
Real-world results62
97Price honesty68
97
Price honesty68
96Prescriber access55
96
Prescriber access55
88Formulary choice68
88
Formulary choice68
95Cancellation fairness60
95
Cancellation fairness60
93Member support52
93
Member support52
Price, coverage & features
| Metric | CoreAge Rx | Lttl |
|---|---|---|
| Verdict Score | 94/100 | 61/100 |
| Grade | A | C |
| Semaglutide | $149/mo | $199/mo |
| Tirzepatide | $349/mo | $279/mo |
| Coverage | All 50 states | Multi-state |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | No | Yes |
CoreAge Rx
What we like
- Flat, all-in monthly price with no intro-rate step-ups after month one
- Both compounded semaglutide and tirzepatide on one account
- Available in all 50 states
- Straightforward, low-friction cancellation
The caveats
- Not the cheapest — flat-price challengers like Trimi Health and Alan Meds undercut its sticker price
- No FDA-approved brand-name option (compounded only)
- Does not yet publicly name its 503A/B pharmacy partner
Lttl
What we like
- The /plans page carries every product against all five tiers — monthly, 3-, 6- and 12-month and a first-month special — so the real month-to-month rate is public
- Price is flat at every dose, so moving up a dose does not raise the monthly bill
- States plainly that its compounded GLP-1s 'are not FDA-approved and have not been evaluated by the FDA for safety, efficacy, or quality'
- Offers an oral dissolving-tablet semaglutide at $229/mo month-to-month for people who want to avoid injections
- Runs a microdose line — low-dose semaglutide or tirzepatide at $149/mo month-to-month — for people sensitive to side effects
The caveats
- Compounded only, and compounded GLP-1s are not FDA-approved; no brand-name Wegovy, Zepbound, Ozempic or Mounjaro
- Partner pharmacies are never named — the site says only 'a partner U.S. pharmacy' — a material gap for a prescription purchase
- The marketed 'Plans start at $129/mo' is the twelve-month prepay rate; month-to-month is $199 semaglutide and $279 tirzepatide
- No public list of states served; eligibility depends on where unnamed partner providers happen to be licensed
- Medication cannot be returned or refunded once it ships, the terms impose individual arbitration with a class-action waiver, and support is email and portal only with no phone line
Our pick — visit
Anyone who wants transparent flat pricing and nationwide access without a teaser-rate bait-and-switch.
Visit CoreAge Rx Read the full CoreAge Rx review →Also worth a look
Shoppers comparing commitment lengths who want the true month-to-month rate visible, or who want an oral or low-dose option instead of a standard injection.
Visit Lttl Read the full Lttl review →Keep comparing
Neither of these has to be the answer: the rivals we rank against CoreAge Rx cover the 7 programmes closest to it, and the same shortlist for Lttl does the reverse.
Or browse the full comparison hub and the complete rankings.
Pricing, states and verification reflect each provider's public disclosures at last review; the Verdict Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.